[Studies on the alkaline granulocyte phosphatase (GAP) in endocrine diseases].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000236:Adenoma; D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000201:enzymology / Q000601:surgery; D000309:Adrenal Insufficiency / Q000201:enzymology*; D000315:Adrenalectomy; D000308:Adrenocortical Hyperfunction / Q000201:enzymology*; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood*; D003480:Cushing Syndrome / Q000201:enzymology; D005260:Female; D006801:Humans; D006957:Hyperostosis Frontalis Interna / Q000201:enzymology; D007027:Hypothalamic Diseases / Q000201:enzymology; D007037:Hypothyroidism / Q000201:enzymology; D007962:Leukocytes / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000201:enzymology*; D009765:Obesity / Q000201:enzymology; D010024:Osteoporosis / Q000201:enzymology
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000469:Alkaline Phosphatase
Untersuchungen über die alkalische Granulozytenphosphatase (GAP) bei endokrinen Erkrankungen.